Intermittent Explosive Disorder Clinical Trial
Official title:
Fluoxetine and Divalproex: Treatment Correlates in IED
This study will compare the medications fluoxetine (Prozac®) and divalproex (Depakote®) for the treatment of aggressive behavior in individuals with Intermittent Explosive Disorder (IED).
IED is a condition characterized by a failure to resist aggressive impulses. IED is a behavioral defined condition for which effective treatments have not been identified. Research suggests that serotonin (5-HT), a chemical that helps regulate mood and emotions, may play a role in the response to pharmacological IED treatments. This study will examine the relationship between 5-HT receptors and response to treatment with fluoxetine or divalproex. In addition, this study will examine people with IED and those without the condition to determine whether there are differences in their 5-HT receptor and transporter systems. Participants in this study will be randomly assigned to receive either fluoxetine, divalproex, or placebo for 12 weeks. Scale ratings will be used to assess the aggression levels of participants. Biologic evaluations of the 5-HT system will be conducted throughout the study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06118567 -
Effect of Nitrous Oxide on Aggression.
|
Phase 2 | |
| Terminated |
NCT00282165 -
Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order
|
Phase 4 | |
| Not yet recruiting |
NCT04819230 -
A Cognitive Bias Modification RCT for Aggression
|
N/A | |
| Completed |
NCT02055638 -
Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder
|
Phase 1/Phase 2 | |
| Completed |
NCT00399698 -
Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
|
Phase 3 | |
| Recruiting |
NCT06118580 -
Neural Correlates During Alcohol Intoxication
|
Phase 2 | |
| Completed |
NCT02048241 -
Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
|
Phase 4 | |
| Not yet recruiting |
NCT05895513 -
Pimavanserin and Aggression and Social Cognition.
|
Phase 2 | |
| Terminated |
NCT03420222 -
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder
|
Phase 2 | |
| Recruiting |
NCT06275607 -
Maladaptive Anger Treatment
|
N/A | |
| Completed |
NCT00127400 -
A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IED
|
Phase 2 | |
| Completed |
NCT00667212 -
Psychotherapy for Intermittent Explosive Disorder
|
Phase 2 |